Adalimumab (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Adalimumab" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

1^st place

399^th place

480^th place

719^th place

1,112^th place

447^th place

792^nd place

102^nd place

411^th place

drugs.com

"Adalimumab Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. 14 May 2018. Diarsipkan dari versi aslinya tanggal 21 November 2020. Diakses tanggal 18 March 2019.
"Adalimumab Pregnancy and Breastfeeding Warnings". Drugs.com. Diarsipkan dari versi aslinya tanggal 17 April 2021. Diakses tanggal 19 March 2019.

"Drug Approval Package: Humira (adalimumab)". U.S. Food and Drug Administration (FDA). 7 April 2017. Diarsipkan dari versi aslinya tanggal 18 February 2020. Diakses tanggal 18 February 2020.

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

"FDA Clears Adalimumab (Humira) for Hidradenitis Suppurativa". Medscape. 11 September 2015. Diarsipkan dari versi aslinya tanggal 21 January 2021. Diakses tanggal 13 October 2017.

"Adalimumab Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. 14 May 2018. Diarsipkan dari versi aslinya tanggal 21 November 2020. Diakses tanggal 18 March 2019.
"FDA Clears Adalimumab (Humira) for Hidradenitis Suppurativa". Medscape. 11 September 2015. Diarsipkan dari versi aslinya tanggal 21 January 2021. Diakses tanggal 13 October 2017.
"Adalimumab Pregnancy and Breastfeeding Warnings". Drugs.com. Diarsipkan dari versi aslinya tanggal 17 April 2021. Diakses tanggal 19 March 2019.
"Drug Approval Package: Humira (adalimumab)". U.S. Food and Drug Administration (FDA). 7 April 2017. Diarsipkan dari versi aslinya tanggal 18 February 2020. Diakses tanggal 18 February 2020.